GMO Media,Inc.

The Group operates digital businesses focused primarily on learning and aesthetic medicine. With its media business at the core, it employs a revenue model combining advertising-based flow revenue and fee-based recurring revenue. By expanding recurring-revenue services in the learning sector, the Group is gradually reducing the proportion of flow revenue and promoting a shift toward a structure centered on recurring revenue. Specifically, it is expanding recurring-revenue businesses, including DX services for aesthetic clinics, and building up recurring-revenue services in the learning sector. As of the end of the interim period of the fiscal year ending December 2025, total assets were ¥5,815,075 thousand, equity was ¥2,906,445 thousand, shareholders’ equity was ¥2,882,597 thousand, and cash and cash equivalents stood at ¥2,973,984 thousand. For the interim period of the fiscal year ending June 2026, revenue was ¥3,376,387 thousand, operating profit was ¥345,778 thousand, ordinary profit was ¥349,445 thousand, and interim net income attributable to owners of the parent was ¥243,885 thousand. The principal segments are the Media Business and the Solutions Business. The Media Business continues to expand recurring revenue, while the Solutions Business has been affected by factors including the impact of revisions to customer contract terms. Going forward, the Group aims to increase its contribution to revenue by strengthening measures for AIO (AI optimization) and expanding its network of partner media outlets.